Clinical Trials Browser

Salivary Gland Neoplasms × sacituzumab govitecan × 1 year × Clear all

NCT05884320 2026-03-20

Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers

Phase 2 Recruiting

Salivary Gland Neoplasms

NCT06923826 2025-07-25

TROP2

Phase 2 Recruiting

Salivary Gland Neoplasms, Thyroid Neoplasms